Cargando…

Clinical and MRI Donor-Site Outcomes After Autograft Harvesting From the Medial Trochlea for Talar Osteochondral Lesions: Minimum 5-Year Clinical Follow-up

BACKGROUND: Autologous osteochondral transplantation (AOT) is a treatment option for large or cystic osteochondral lesions of the talus (OLTs), with promising clinical results. However, donor-site morbidity (DSM) has always been a concern with this procedure. PURPOSE: To investigate the clinical and...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Changjun, Li, Xingchen, Zhu, Yuan, Yang, Chonglin, Xu, Xiangyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459477/
https://www.ncbi.nlm.nih.gov/pubmed/36089925
http://dx.doi.org/10.1177/23259671221120075
_version_ 1784786518837035008
author Guo, Changjun
Li, Xingchen
Zhu, Yuan
Yang, Chonglin
Xu, Xiangyang
author_facet Guo, Changjun
Li, Xingchen
Zhu, Yuan
Yang, Chonglin
Xu, Xiangyang
author_sort Guo, Changjun
collection PubMed
description BACKGROUND: Autologous osteochondral transplantation (AOT) is a treatment option for large or cystic osteochondral lesions of the talus (OLTs), with promising clinical results. However, donor-site morbidity (DSM) has always been a concern with this procedure. PURPOSE: To investigate the clinical and radiological outcomes of autograft harvesting from the medial trochlea for OLTs. STUDY DESIGN: Case series; Level of evidence, 4. METHODS: A total of 46 consecutive patients were included after AOT procedures for OLTs, with donor autografts (single or double plugs) harvested from the medial trochlea of the ipsilateral knee. Lysholm scores were collected postoperatively at 12-month intervals to assess clinical outcomes. Postoperative magnetic resonance imaging (MRI) was used to assess the donor site using the MOCART (magnetic resonance observation of cartilage repair tissue) score. DSM was evaluated at 12-month intervals. Statistical analysis was performed to compare patients treated with single-plug and double-plug AOT procedures and establish whether there was any correlation between MOCART and Lysholm scores. RESULTS: The mean follow-up period was 98.3 months (range, 67-144 months). The Lysholm scores for all patients were 92.5 ± 6.1 and 99.9 ± 0.2 at the 12-month and final follow-ups, respectively. MRI of the donor sites was taken at an average of 93.8 ± 20.5 (range, 61-141) months postoperatively, and the mean MOCART score was 76.2 ± 4.9. The overall incidence of DSM in this study was 4.3% at 12 months, postoperatively, which decreased to 0% at the 24-month follow-up. There was no significant difference in either the Lysholm score (P = .16) or the MOCART score (P = .83) between the single-plug and double-plug groups at the final follow-up. There were no significant correlations between MOCART and Lysholm scores and patient age, number of grafts, or body mass index. CONCLUSION: According to the study findings, the DSM of donor autografts harvested from the medial trochlea was low, and the number (single or double) of grafts did not affect the functional outcome.
format Online
Article
Text
id pubmed-9459477
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-94594772022-09-10 Clinical and MRI Donor-Site Outcomes After Autograft Harvesting From the Medial Trochlea for Talar Osteochondral Lesions: Minimum 5-Year Clinical Follow-up Guo, Changjun Li, Xingchen Zhu, Yuan Yang, Chonglin Xu, Xiangyang Orthop J Sports Med Article BACKGROUND: Autologous osteochondral transplantation (AOT) is a treatment option for large or cystic osteochondral lesions of the talus (OLTs), with promising clinical results. However, donor-site morbidity (DSM) has always been a concern with this procedure. PURPOSE: To investigate the clinical and radiological outcomes of autograft harvesting from the medial trochlea for OLTs. STUDY DESIGN: Case series; Level of evidence, 4. METHODS: A total of 46 consecutive patients were included after AOT procedures for OLTs, with donor autografts (single or double plugs) harvested from the medial trochlea of the ipsilateral knee. Lysholm scores were collected postoperatively at 12-month intervals to assess clinical outcomes. Postoperative magnetic resonance imaging (MRI) was used to assess the donor site using the MOCART (magnetic resonance observation of cartilage repair tissue) score. DSM was evaluated at 12-month intervals. Statistical analysis was performed to compare patients treated with single-plug and double-plug AOT procedures and establish whether there was any correlation between MOCART and Lysholm scores. RESULTS: The mean follow-up period was 98.3 months (range, 67-144 months). The Lysholm scores for all patients were 92.5 ± 6.1 and 99.9 ± 0.2 at the 12-month and final follow-ups, respectively. MRI of the donor sites was taken at an average of 93.8 ± 20.5 (range, 61-141) months postoperatively, and the mean MOCART score was 76.2 ± 4.9. The overall incidence of DSM in this study was 4.3% at 12 months, postoperatively, which decreased to 0% at the 24-month follow-up. There was no significant difference in either the Lysholm score (P = .16) or the MOCART score (P = .83) between the single-plug and double-plug groups at the final follow-up. There were no significant correlations between MOCART and Lysholm scores and patient age, number of grafts, or body mass index. CONCLUSION: According to the study findings, the DSM of donor autografts harvested from the medial trochlea was low, and the number (single or double) of grafts did not affect the functional outcome. SAGE Publications 2022-09-06 /pmc/articles/PMC9459477/ /pubmed/36089925 http://dx.doi.org/10.1177/23259671221120075 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc-nd/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 License (https://creativecommons.org/licenses/by-nc-nd/4.0/) which permits non-commercial use, reproduction and distribution of the work as published without adaptation or alteration, without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Article
Guo, Changjun
Li, Xingchen
Zhu, Yuan
Yang, Chonglin
Xu, Xiangyang
Clinical and MRI Donor-Site Outcomes After Autograft Harvesting From the Medial Trochlea for Talar Osteochondral Lesions: Minimum 5-Year Clinical Follow-up
title Clinical and MRI Donor-Site Outcomes After Autograft Harvesting From the Medial Trochlea for Talar Osteochondral Lesions: Minimum 5-Year Clinical Follow-up
title_full Clinical and MRI Donor-Site Outcomes After Autograft Harvesting From the Medial Trochlea for Talar Osteochondral Lesions: Minimum 5-Year Clinical Follow-up
title_fullStr Clinical and MRI Donor-Site Outcomes After Autograft Harvesting From the Medial Trochlea for Talar Osteochondral Lesions: Minimum 5-Year Clinical Follow-up
title_full_unstemmed Clinical and MRI Donor-Site Outcomes After Autograft Harvesting From the Medial Trochlea for Talar Osteochondral Lesions: Minimum 5-Year Clinical Follow-up
title_short Clinical and MRI Donor-Site Outcomes After Autograft Harvesting From the Medial Trochlea for Talar Osteochondral Lesions: Minimum 5-Year Clinical Follow-up
title_sort clinical and mri donor-site outcomes after autograft harvesting from the medial trochlea for talar osteochondral lesions: minimum 5-year clinical follow-up
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459477/
https://www.ncbi.nlm.nih.gov/pubmed/36089925
http://dx.doi.org/10.1177/23259671221120075
work_keys_str_mv AT guochangjun clinicalandmridonorsiteoutcomesafterautograftharvestingfromthemedialtrochleafortalarosteochondrallesionsminimum5yearclinicalfollowup
AT lixingchen clinicalandmridonorsiteoutcomesafterautograftharvestingfromthemedialtrochleafortalarosteochondrallesionsminimum5yearclinicalfollowup
AT zhuyuan clinicalandmridonorsiteoutcomesafterautograftharvestingfromthemedialtrochleafortalarosteochondrallesionsminimum5yearclinicalfollowup
AT yangchonglin clinicalandmridonorsiteoutcomesafterautograftharvestingfromthemedialtrochleafortalarosteochondrallesionsminimum5yearclinicalfollowup
AT xuxiangyang clinicalandmridonorsiteoutcomesafterautograftharvestingfromthemedialtrochleafortalarosteochondrallesionsminimum5yearclinicalfollowup